<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">352688</id>
  <title nil="true"/>
  <common-name>N-[4-[(3-amino-10-methylacridin-10-ium-9-yl)amino]phenyl]-4-[(1-methylpyridin-1-ium-4-yl)amino]benzamide</common-name>
  <description>N-[4-[(3-amino-10-methylacridin-10-ium-9-yl)amino]phenyl]-4-[(1-methylpyridin-1-ium-4-yl)amino]benzamide is a chemical compound with the formula C33H30N6O+2. With an average molecular weight of 526.60 g/mol, N-[4-[(3-amino-10-methylacridin-10-ium-9-yl)amino]phenyl]-4-[(1-methylpyridin-1-ium-4-yl)amino]benzamide is a heavy molecule.</description>
  <cas>113844-56-7</cas>
  <pubchem-id>50243</pubchem-id>
  <chemical-formula>C33H30N6O+2</chemical-formula>
  <weight>526.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T19:09:52Z</created-at>
  <updated-at type="dateTime">2026-08-31T19:09:52Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)NC4=C5C=CC(=CC5=[N+](C6=CC=CC=C64)C)N</moldb-smiles>
  <moldb-formula>C33H30N6O+2</moldb-formula>
  <moldb-inchi>InChI=1S/C33H28N6O/c1-38-19-17-27(18-20-38)35-24-10-7-22(8-11-24)33(40)37-26-14-12-25(13-15-26)36-32-28-5-3-4-6-30(28)39(2)31-21-23(34)9-16-29(31)32/h3-21H,1-2H3,(H3,34,36,37,40)/p+2</moldb-inchi>
  <moldb-inchikey>QUSKQYORRKZTMK-UHFFFAOYSA-P</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">526.2481096</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM348581</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[4-[(3-amino-10-methylacridin-10-ium-9-yl)amino]phenyl]-4-[(1-methylpyridin-1-ium-4-yl)amino]benzamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Anilides</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0302973</sync-id>
  <structure-inchikey>QUSKQYORRKZTMK-UHFFFAOYSA-P</structure-inchikey>
  <structure-fingerprint>100000000000000000100000000000000000001000008000400000000000000001001000002100000000000000000000000000000000000000120000040001000000000000000000000000000010400000010000000100080000000000000000000000100001000018000000040000408800000000000000080009000000100000000000000000000080000000000000000040000084000000000000000004000002000000000080000000000040000000000008000000000400000004000000004000200000000001000008000008800000040000000000400000000000000200000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>7016c0008d12865081805be48138a2001a00148281052070803d60428224e9cc6c222050138000000100492842c0000004600224c08d322509ee653980a04010c7110c8916c0340000901240127202000805859551211f3342041d62542258042c28052f004e2221404c8480dd94004c208680708121dd0671192c4c02710312104d18194ef8820a08072250ca2c0088391d981244449e8b50230c2064c004a000d3101700b2c2300a040968057c3d144ac00402a941084810a04a304cc04212a08000a444d8033311888484541142990c410010034450008d6122802a200304913041101889032013080411d913a0a20850063094c2040e5108908072080e06</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAALQAAAIABBgBgAAAAAQMHYCoAAAAB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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:50:25Z</structure-indexed-at>
</compound>
